Mitapivat versus Placebo for Pyruvate Kinase Deficiency. Reply
DSpace/Manakin Repository
Mitapivat versus Placebo for Pyruvate Kinase Deficiency. Reply
Al-Samkari, Hanny; Beynon, Vanessa; van Beers, Eduard J.
(2022) The New England journal of medicine, volume 386, issue 26, pp. 2538 - 2539
(Comment)
Download/Full Text
The full text of this publication is not available.
Version on publisher website for UU-students and staff
Version on publisher website
Keywords: Anemia, Hemolytic, Congenital Nonspherocytic, Humans, Piperazines, Pyruvate Kinase/deficiency, Pyruvate Metabolism, Inborn Errors, Quinolines, General Medicine, Comment, Letter
DOI:
https://doi.org/10.1056/NEJMc2206275
ISSN: 0028-4793
Publisher: Massachussetts Medical Society
(Peer reviewed)